Welcome : Guest

Opko Health, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Opko Health, Inc., which is principally a Healthcare Company. Illustrated with 59 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-34515
Price: $2950
Company Type: Public
Pages: 65
Date: November 2016
Market Data Tables: 59

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Opko Health, Inc.’s Revenues by Category Worldwide (2015) in Percentage for Revenue from Services (Diagnostics), Product Revenues (Pharmaceutical), and Revenue from Transfer of Intellectual Property......6
Table 2: Opko Health, Inc.’s Sales by Geographic Region Worldwide (2015) in Percentage for United States, Ireland, Chile, Spain, Israel, and Mexico......7
Growth Hormones......9
Table 3: Growth Hormone Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......9
Table 4: Growth Hormone Market by Growth Disorder Indication in Europe (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Other......10
Table 5: Growth Hormone Market by Growth Disorder Indication in Japan (2015) - Percentage Share Breakdown by Value for Pediatric Growth Hormone Deficiency (GHD) and Turner Syndrome......11
Table 6: Growth Hormone Market by Growth Disorder Indication in the US (2015) - Percentage Share Breakdown by Value for Adult Growth Hormone Deficiency (GHD), Idiopathic Short Stature (ISS), Pediatric Growth Hormone Deficiency (GHD), Turner Syndrome and Other......12
Human Growth Hormones (hGH)......13
Table 7: Human Growth Hormone (hGH) Market by Growth Disorder Indication Worldwide (2015) - Percentage Share Breakdown by Value for Idiopathic Short Stature, Pediatric Growth Disorder Deficiency (GHD), Turner Syndrome and Others......13
Table 8: Human Growth Hormone Sales by Product in the US (2015) - Percentage Share Breakdown by Value for Genotropin (Pfizer), Humatrope (Eli Lilly), Norditropin (Novo Nordisk), Nutropin (Roche), Saizen, serostim (Merck KGaA) and Others......14
Pediatric Growth Hormone Deficiency (GHD)......15
Table 9: Pediatric Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan and United States......15
Table 10: Pediatric Growth Hormone Deficiency (GHD) Market by Product in the US (2015) - Percentage Share Breakdown by Value Genotropin, Humatrope, Norditropin and FlexPro (NordiFlex), Nutropin AQ and Others......16
Adult Growth Hormone Deficiency (GHD)......17
Table 11: Adult Growth Hormone Deficiency (GHD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe and United States......17
Hemophilia......18
Table 12: Hemophilia Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hemophilia A, Hemophilia B, Inhibitor, and Von Willebrand Disease......18
Table 13: Hemophilia Diagnosis and Treatments Rates by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Diagonised, Pristine Joints, Prophylactic, Treated, and Others......19
Table 14: Haemophilia by Severity Stage Worldwide (2015) - Percentage Market Share Breakdown by No. of Patients for Mild, Moderate and Severe......20
Table 15: Haemophilia Patient Population by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Haemophilia A (Factor VIII Deficiency) and Haemophilia B (Factor IX Deficiency)......21
Table 16: Continuous Prophylaxis (Moderate) Treatment for Hemophilia A Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......22
Table 17: Continuous Prophylaxis Treatment (Severe) for Hemophilia A Patients by Age Group Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......23
Table 18: On-Demand (Moderate Patient) Treatment for Hemophilia A Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......24
Table 19: On-Demand (Severe Patient) Treatment for Hemophilia A Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......25
Table 20: Haemophilia B - Recombinant (Benefix) Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Emerging Markets, Europe, US, and Others......26
Table 21: Immune Tolerance Therapy (Patient) Treatment for Hemophilia A Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......27
Table 22: Intermittent Prophylaxis (Moderate Patient Equivalent) Treatment for Hemophilia A Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......28
Table 23: Intermittent Prophylaxis (Severe Patient Equivalent) Treatment for Hemophilia A Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......29
Table 24: U.S. Hemophilia Market Patients Treated/Year (2014)......30
Obesity......31
Table 25: Obesity Market by Age Group in the US (2015) - Percentage Share Breakdown by Value for Aged 18-29, Aged 30-44, Aged 45-64, and Others......31
Table 26: Obesity Market by Category in the US (2015) - Percentage Share Breakdown by Value for Blacks, Hispanics, Whites, and Others......32
Table 27: Obesity Market by Region in the US (2015) - Percentage Share Breakdown by Value for East, Midwestern, South, and West......33
Table 28: Prevalence of Obesity by Type in the US (2015) - Percentage Market Share Breakdown by Volume for Extreme Obesity, Normal Weight or Under-Weight, Obesity, Overweight......34
Parkinson's Disease......35
Table 29: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......35
Table 30: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65‐69, 70‐74, 75‐79, 80‐84 and 85+......36
Asthma Drugs......37
Table 31: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......37
Table 32: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......38
Table 33: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......39
Chronic Obstructive Pulmonary Disease (COPD) Drugs......40
Table 34: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......40
Table 35: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......41
Table 36: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......42
Table 37: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......43
Point-of-care Diagnostics......44
Table 38: Point-of-care Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Blood Chemistry, Cardiac Markers, Drug & Alcohol, Glucose Monitoring, Pregnancy, and Others......44
Diagnostic Testing......45
Table 39: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......45
Table 40: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......46
Table 41: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......47
Table 42: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......48
Table 43: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......49
Table 44: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......50
Table 45: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......51
Table 46: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......52
Phosphate Binder Drugs......53
Table 47: Market Shares of Leading Phosphate Binder Drugs for Treatment of Hyperkalemia and Hyperphosphatemia Worldwide (2015) - Percentage Share Breakdown by Value for Calcium Acetate, Sevelamer and Others......53
Human Growth Hormones (HGH)......54
Table 48: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......54
Table 49: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......55
Table 50: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......56
Obesity Therapeutics......57
Table 51: Market Shares of Leading Obesity Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, and Others......57
Ophthalmology Drugs......58
Table 52: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......58
Table 53: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......59
Influenza Vaccines......60
Table 54: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......60
Cyclic Vomiting Syndrome (CVS) Medicines......61
Table 55: Market Shares of Leading Cyclic Vomiting Syndrome (CVS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......61
Table 56: Opko Health, Inc.’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Chile, Spain, Israel and Mexico......62
Table 57: Opko Health, Inc.’s Sales by Business Segment Worldwide (2013) in Percentage for Pharmaceuticals, Diagnostics and Corporate......63
Table 58: Opko Health, Inc.’s Revenues by Category Worldwide (2011-2013) in US$ Thousands for Products, Revenue from Services and Revenue from Transfer of Intellectual Property......64
Table 59: Opko Health, Inc.'s Sales by Product Segment Worldwide (2013) in Percentage for Digirad Imaging Solutions ("DIS") and Diagnostic Imaging......65